News & Updates

More evidence for remdesivir in severe COVID-19

10 May 2023 by

Treatment with remdesivir reduced mortality in a large cohort of hospitalized patients requiring high-flow oxygen, according to a study presented at ECCMID 2023.

More evidence for remdesivir in severe COVID-19

10 May 2023

No difference in post-COVID vaccination side effects for BRCA1/2 carriers in Singapore

09 May 2023 by

Individuals with germline genetic alterations, particularly the BRCA1/2 pathogenic/likely pathogenic variant (PV/LPV), do not appear to experience any significant increase in post-COVID vaccination side effects, as reported in a study from Singapore.

No difference in post-COVID vaccination side effects for BRCA1/2 carriers in Singapore

09 May 2023

Prior carbapenem use ups S. maltophilia bloodstream infection in children

09 May 2023

Children with prior use of carbapenem are at increased risk of developing Stenotrophomonas maltophilia bloodstream infection (BSI), suggests a study. In addition, admission to the paediatric intensive care unit (PICU) due to BSI and prior glycopeptide use are significantly associated with the mortality rate in patients with S. maltophilia BSIs

Prior carbapenem use ups S. maltophilia bloodstream infection in children

09 May 2023

Flu can trigger a fatal heart attack

09 May 2023 by

Coming down with influenza – commonly called flu – can increase the risk of having a heart attack by sixfold. This is the takeaway from a replication study presented at ECCMID 2023.

Flu can trigger a fatal heart attack

09 May 2023

Male sex, delayed sternal closure tied to postoperative candidemia in children with CHD

08 May 2023

Though uncommon, candidemia following cardiac surgery in children with congenital heart defect (CHD) proves to be a serious complication, reveals a study. The most common cause of non-albicans candidemia is the high frequency of fluconazole-resistant C. parapsilosis.

Male sex, delayed sternal closure tied to postoperative candidemia in children with CHD

08 May 2023

Ceftriaxone, ciprofloxacin not inferior to cefotaxime for spontaneous bacterial peritonitis

08 May 2023 by

Antibiotics, such as cefotaxime, ceftriaxone, and ciprofloxacin, demonstrate similar efficacy against spontaneous bacterial peritonitis (SBP), reports a study. Additionally, ciprofloxacin or ceftriaxone is not inferior to cefotaxime, which is the current standard for empirical therapy of community-acquired SBP.

Ceftriaxone, ciprofloxacin not inferior to cefotaxime for spontaneous bacterial peritonitis

08 May 2023

Oncologists underestimate patients’ motivation to attend appointments during COVID-19 pandemic

08 May 2023 by

Oncologists underestimate patients’ willingness to attend appointments to avoid treatment interruptions during the COVID-19 pandemic, according to a multidisciplinary cross-sectional survey, which shows unaltered willingness to attend scheduled appointments in most cancer patients.

Oncologists underestimate patients’ motivation to attend appointments during COVID-19 pandemic

08 May 2023

COVID-19 long-term sequelae and complications

06 May 2023 by

Long COVID, sometimes referred to as post-acute sequelae of COVID-19, is still highly prevalent despite improved acute treatments, the emergence of newer variants, and wider vaccination coverage, says an expert at ECCMID 2023.

COVID-19 long-term sequelae and complications

06 May 2023

Fluvoxamine plus budesonide helps prevent severe COVID-19

05 May 2023

High-risk outpatients with early-onset COVID-19 who are treated with oral fluvoxamine plus inhaled budesonide have a reduced incidence of severe disease that warrants advanced care, reveals a study.

Fluvoxamine plus budesonide helps prevent severe COVID-19

05 May 2023

Functional loss common in patients with RSV

05 May 2023 by

For many older adults, functional decline, loss of independence, and ending up in a nursing home is something they dread more than death itself, said Professor Anne Fausley from the University of Rochester School of Medicine, Rochester, New York, US at ECCMID 2023.

Functional loss common in patients with RSV

05 May 2023

News & Updates

Filter by Specialty:

Specialty:

More evidence for remdesivir in severe COVID-19

More evidence for remdesivir in severe COVID-19

No difference in post-COVID vaccination side effects for BRCA1/2 carriers in Singapore

No difference in post-COVID vaccination side effects for BRCA1/2 carriers in Singapore

Prior carbapenem use ups S. maltophilia bloodstream infection in children

Prior carbapenem use ups S. maltophilia bloodstream infection in children

Flu can trigger a fatal heart attack

Flu can trigger a fatal heart attack

Male sex, delayed sternal closure tied to postoperative candidemia in children with CHD

Male sex, delayed sternal closure tied to postoperative candidemia in children with CHD

Ceftriaxone, ciprofloxacin not inferior to cefotaxime for spontaneous bacterial peritonitis

Ceftriaxone, ciprofloxacin not inferior to cefotaxime for spontaneous bacterial peritonitis

Oncologists underestimate patients’ motivation to attend appointments during COVID-19 pandemic

Oncologists underestimate patients’ motivation to attend appointments during COVID-19 pandemic

COVID-19 long-term sequelae and complications

COVID-19 long-term sequelae and complications

Fluvoxamine plus budesonide helps prevent severe COVID-19

Fluvoxamine plus budesonide helps prevent severe COVID-19

Functional loss common in patients with RSV

Functional loss common in patients with RSV